Dr. Jaffe's insights on Nrf1 and Nrf2 activators, as well as Nrf2 inhibitors, offer a promising avenue to overcome chemoresistance. His expertise in cryptocurrency and finance equips him with a unique perspective, bridging the gap between biotechnology and economic realities. His opinion is a must-read for those seeking innovative solutions in healthcare.